FDA NDC Directory · JSON-LD · Markdown

Lisdexamfetamine Dimesylate

NDC 0527-4665 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerLannett Company, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215802
Dosage form / routeCAPSULE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (50 mg/1)
Marketing started20230825
Package count1

External sources

Source: openFDA. Public-domain (CC0).